These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 628007)

  • 1. A ureido group containing analogue of oxytocin comprising eight amino acid residues.
    Bodanszky M; Fagan DT; Walter R; Smith CW
    J Med Chem; 1978 Mar; 21(3):306-8. PubMed ID: 628007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin.
    Smith CW; Skala G; Walter R
    J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones.
    Stahl GL; Smith CW; Walter R; Tsegenidis T; Stavropoulos G; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Feb; 23(2):213-7. PubMed ID: 7359537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide.
    Ting YF; Smith CW; Stahl GL; Walter R; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Jun; 23(6):693-5. PubMed ID: 7392037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and some pharmacological properties of [Glu(OMe)4]oxytocin and [Mpr1, Glu(OMe)4]oxytocin.
    Photaki I; Tzougraki C; Kotsira-Engonopoulos C
    Int J Pept Protein Res; 1979 Apr; 13(4):426-33. PubMed ID: 457336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
    Roy J; Roy U; Gazis DC; Schwartz IL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R; Smith CW; Roy J; Formento A
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some pharmacological actions of four synthetic analogues of oxytocin.
    BERDE B; DOEPFNER W; KONZETT H
    Br J Pharmacol Chemother; 1957 Jun; 12(2):209-14. PubMed ID: 13446374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
    Stahl GL; Walter R
    J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
    Nestor JJ; Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
    Moore S; Felix AM; Meienhofer J; Smith CW; Walter R
    J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologically active macromolecular forms of oxytocin. [8-Lysine]oxytocin as a suitable ligand.
    Snell CR; Smyth DG
    Biochem J; 1977 Jul; 165(1):43-7. PubMed ID: 889573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
    Nestor JJ; Ferger MF; du Vigneaud V
    J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin.
    Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J
    J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some pharmacological properties of a synthetic oxytocin analogue [1-N-carbamoyl-hemicystine-2-O-methyltyrosine]-oxytocin (carbamoyl-methyloxytocin), an antagonist to the neurohypophysial hormones.
    Bisset GW; Clark BJ; Krejcí I; Polácek I; Rudinger J
    Br J Pharmacol; 1970 Oct; 40(2):342-60. PubMed ID: 4321760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity.
    Wittelsberger A; Patiny L; Slaninova J; Barberis C; Mutter M
    J Med Chem; 2005 Oct; 48(21):6553-62. PubMed ID: 16220972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
    Lundell EO; Ferger MF
    J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
    Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
    J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin.
    Walter R; Stahl GL; Caplaneris T; Cordopatis P; Theodoropoulos D
    J Med Chem; 1979 Jul; 22(7):890-3. PubMed ID: 448689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.